Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients

Novel anti-myeloma agents have improved patient response rates, which are historically based on reductions of the M-protein. These methods can be inaccurate for quantifying M-proteins at low concentrations. We compared the consistency and clinical impact of response assignment by electrophoretic and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Leukemia
Hlavní autoři: Michallet, M, Chapuis-Cellier, C, Dejoie, T, Lombard, C, Caillon, H, Sobh, M, Moreau, P, Attal, M, Avet-Loiseau, H
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808078/
https://ncbi.nlm.nih.gov/pubmed/28663581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2017.209
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky